Markus Sieger, Director at Cyclo Therapeutics, Inc. (CTDH), bought 500,000 shares at $0.10 ($50K) on 2020-04-24, disclosed to the SEC on 2020-04-27.
Open-market purchase of $50k CTDH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CYTH | BUY | 2021-03-30 | $81K | — | Filing → |
| CYTH | BUY | 2021-01-27 | $64K | — | Filing → |
| CTDH | BUY | 2019-08-26 | $22K | — | Filing → |